Form 8-K - Current report:
SEC Accession No. 0001193125-22-264856
Filing Date
2022-10-19
Accepted
2022-10-19 06:26:37
Documents
16
Period of Report
2022-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d399364d8k.htm   iXBRL 8-K 45395
2 EX-99.1 d399364dex991.htm EX-99.1 29367
3 EX-99.2 d399364dex992.htm EX-99.2 12630
8 GRAPHIC g399364g85e59.jpg GRAPHIC 13992
  Complete submission text file 0001193125-22-264856.txt   288915

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zyme-20221018.xsd EX-101.SCH 3586
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zyme-20221018_def.xml EX-101.DEF 14289
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20221018_lab.xml EX-101.LAB 23487
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20221018_pre.xml EX-101.PRE 15177
10 EXTRACTED XBRL INSTANCE DOCUMENT d399364d8k_htm.xml XML 5457
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 206-337-1030
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 221317193
SIC: 2834 Pharmaceutical Preparations